Bufetolol

In this article we are going to explore the topic of Bufetolol and its impact on our contemporary society. Bufetolol is a skin that has captured the attention of experts and enthusiasts alike, and its relevance has only grown in recent years. Throughout this article, we will examine different facets of Bufetolol, from its history and evolution to its implications in today's world. Through detailed analysis, we hope to shed light on this topic and provide our readers with a deeper understanding of Bufetolol and its importance in the modern world.

Bufetolol
Names
IUPAC name
1-(tert-Butylamino)-3-propan-2-ol
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
KEGG
UNII
  • InChI=1S/C18H29NO4/c1-18(2,3)19-11-14(20)12-22-16-8-4-5-9-17(16)23-13-15-7-6-10-21-15/h4-5,8-9,14-15,19-20H,6-7,10-13H2,1-3H3
    Key: AKLNLVOZXMQGSI-UHFFFAOYSA-N
  • InChI=1/C18H29NO4/c1-18(2,3)19-11-14(20)12-22-16-8-4-5-9-17(16)23-13-15-7-6-10-21-15/h4-5,8-9,14-15,19-20H,6-7,10-13H2,1-3H3
    Key: AKLNLVOZXMQGSI-UHFFFAOYAN
  • CC(C)(C)NCC(COC1=CC=CC=C1OCC2CCCO2)O
Properties
C18H29NO4
Molar mass 323.433 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa).

Bufetolol is a beta-adrenoceptor antagonist.[1]

References

  1. ^ Sada, H; Harada, S; Ban, T (1983). "Effects of beta-adrenoceptor blocking agents of N-tertiary butyl derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles". Naunyn-Schmiedeberg's Archives of Pharmacology. 324 (1): 50–7. doi:10.1007/bf00647838. PMID 6138715.
Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.